Aptose Biosciences (APTO) Reports Q4 Loss of $0.38
Tweet
Share
E-mailGet Alerts APTO Hot Sheet
Join SI Premium – FREE
Aptose Biosciences (NASDAQ: APTO) reported Q4 EPS of ($0.38), versus ($0.31) reported last year.
For earnings history and earnings-related data on Aptose Biosciences (APTO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- Aon names interim CFO as Edmund Reese exits the firm
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
